Long-term impact of the 70-gene signature on breast cancer outcome

Several studies have validated the prognostic value of the 70-gene prognosis signature (MammaPrint(R)), but long-term outcome prediction of these patients has not been previously reported. The follow-up of the consecutively treated cohort of 295 patients (<53 years) with invasive breast cancer (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th., Bernards, R., van de Vijver, M. J., van’t Veer, L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907672/
https://www.ncbi.nlm.nih.gov/pubmed/24445566
http://dx.doi.org/10.1007/s10549-013-2831-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907672/
https://www.ncbi.nlm.nih.gov/pubmed/24445566
http://dx.doi.org/10.1007/s10549-013-2831-4

Ejemplares similares